In humans, DPP-4is, including sitagliptin, have demonstrated a significant ability to decrease systemic inflammatory mediators such as CRP and IL-6 in patients with T2DM [82]
The post says patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe pancreatitis should not use semaglutide and therefore should not switch formulations
Superficial confirmed BCC can be treated with imiquimod (subsidised under Special Authority criteria) when standard treatment options, including surgical excision, are contraindicated or inappropriate (Table 2)
While some studies on red light therapy and cold exposure show promising benefits, the overall routine remains pricey and experimental
Taking it alongside a carbohydrate-containing meal is a common approach, since that may aid uptake